Showing results (191-200 of 243) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|April 17, 2025
IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma modelsKirit Singh, Kelly M Hotchkiss, Sarah L Cook, et al.
Neurosurgery|November 27, 2018
Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only PatientsAlireza M Mohammadi, Mayur Sharma, Thomas L Beaumont, et al.
Advances in Radiation Oncology|June 1, 2022
Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution ExperienceCollin L Kent, Yvonne M Mowery, Olayode Babatunde, et al.
Advances in Radiation Oncology|June 20, 2025
Multi-institutional Outcomes after Stereotactic Radiosurgery for Gastrointestinal Brain MetastasesJamiluddin J Qazi, David J Carpenter, Jim Leng, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2020
Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting StandardsScott G Soltys, Michael T Milano, Jinyu Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2019
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing DiseaseHanna R Kemeny, Aladine A Elsamadicy, S Harrison Farber, et al.
Oncoimmunology|June 7, 2018
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastomaCarter M Suryadevara, Rupen Desai, Melissa L Abel, et al.
CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastomaJames J Vredenburgh, Annick Desjardins, David A Reardon, et al.
Practical Radiation Oncology|May 24, 2016
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice GuidelineAlvin R Cabrera, John P Kirkpatrick, John B Fiveash, et al.
Pageof 25